In this episode of the PPTI Podcast, Simo Ellilä, CEO of Enifer, discusses the company’s latest milestone — achieving self-affirmed GRAS status for its Pekilo mycoprotein in the USA. He explains how this regulatory step opens the door to early market entry and pilot partnerships while laying the groundwork for full FDA approval.

Simo highlights Pekilo’s distinctive shelf-stable format, its versatility across applications from dairy alternatives to breakfast cereals, and its neutral taste profile that helps solve one of the biggest challenges in plant proteins: off-flavors. He also underscores that consumer acceptance ultimately depends on two key factors – taste and price – and shares how Enifer’s heritage technology, sustainability-first mindset, and phased entry through the pet food market are shaping its long-term growth strategy.